DataMeds AI, Inc. SEC filings MEDS
DataMeds AI, Inc. has 176 filings in SEC EDGAR's recent list, going back to Jul 22, 2024. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| DRS/A | Filing | Jun 11, 2026 | — |
| PRER14A | Filing | May 15, 2026 | — |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| EFFECT | Filing | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 5, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2026 | — |
| PRER14C | Filing | Mar 25, 2026 | — |
| DRS | Filing | Feb 11, 2026 | — |
| NT 10-Q | Filing | Nov 14, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Sep 25, 2025 | — |
| CORRESP | Letter to the SEC | Sep 23, 2025 | — |
| CORRESP | Letter to the SEC | Sep 12, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Aug 28, 2025 | — |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Aug 8, 2025 | — |
| EFFECT | Filing | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 6, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2025 | — |
| DRS | Filing | Apr 15, 2025 | — |
| DRSLTR | Filing | Apr 14, 2025 | — |
| CERT | Filing | Feb 20, 2025 | — |
| 8-A12B | Filing | Feb 18, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Dec 17, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2024 | — |
| CORRESP | Letter to the SEC | Dec 6, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2024 | — |
| CORRESP | Letter to the SEC | Nov 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2024 | — |
| CORRESP | Letter to the SEC | Sep 27, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 2, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2024 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- MEDS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tampa, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2030763
- Former names
- Wellgistics Health, Inc. (until Jul 21, 2026); Danam Health, Inc (until Sep 27, 2024)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.